URI
65
5
WU
32
2
CINF
53
2
HSIC
56
5
FITB
63
3
TJX
64
2
PVH
62
5
BF.B
33
2
SWK
64
5
TDC
80
4
NRG
49
-3
AON
54
2
DE
63
3
HD
57
2
UA
50
-9
CSCO
67
4
EL
25
4
M
37
12
CPB
30
6
STZ
54
-3
URI
65
5
WU
32
2
CINF
53
2
HSIC
56
5
FITB
63
3
TJX
64
2
PVH
62
5
BF.B
33
2
SWK
64
5
TDC
80
4
NRG
49
-3
AON
54
2
DE
63
3
HD
57
2
UA
50
-9
CSCO
67
4
EL
25
4
M
37
12
CPB
30
6
STZ
54
-3
Financhill
Back

FibroGen 10K Form

Buy
54

FGEN
FibroGen

Last Price:
0.39
Seasonality Move:
50.95%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2023-11-06 10Q FGEN/FibroGen Quarterly
2023-08-07 10Q FGEN/FibroGen Quarterly
2023-05-08 10Q FGEN/FibroGen Quarterly
2022-11-07 10Q FGEN/FibroGen Quarterly
2022-08-08 10Q FGEN/FibroGen Quarterly
2022-05-09 10Q FGEN/FibroGen Quarterly

Receive FGEN News And Ratings

See the #1 stock for the next 7 days that we like better than FGEN

FGEN Financial Statistics

Sales & Book Value

Annual Sales: $147.75M
Cash Flow: $-8.46M
Price / Cash Flow: 0
Annual Sales: $-2.42
Price / Book: 0

Profitability

EPS (TTM): -1.23000
Net Income (TTM): $-121.79M
Gross Margin: $128.9M
Return on Equity: 0%
Return on Assets: -33.69%

FibroGen Earnings Forecast

Key FibroGen Financial Ratios

  • The Gross Profit Margin over the past 11 years for FGEN is 87.24%.
  • The Selling, General & Administrative Expenses for FGEN have been equal to 78.00% of Gross Profit Margin.
  • The Research & Development expenses have been 191.44% of Revenue.
  • The Interest Expense is -5.46% of Operating Income.
  • The Net Earning history of FGEN is -192.37% of Total Revenues.
  • Per Share Earnings over the last 12 years have been positive in 6 years.

FibroGen Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: FGEN
CUSIP: 31572Q
Website: fibrogen.com

Debt

Debt-to-Equity Ratio: -0.3
Current Ratio: 1.28
Quick Ratio: 1.13

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

FGEN Technical Analysis vs Fundamental Analysis

Buy
54
FibroGen (FGEN) is a Buy

Is FibroGen a Buy or a Sell?

  • FibroGen stock is rated a Buy
    The current FibroGen [FGEN] share price is $0.40. The Score for FGEN is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.